Bio-Connect
IHC-P analysis of formalin fixed human placenta tissue using GTX52502 VEGF165b antibody [7F17].
IHC-P analysis of formalin fixed human placenta tissue using GTX52502 VEGF165b antibody [7F17].
IHC-P analysis of formalin fixed human placenta tissue using GTX52502 VEGF165b antibody [7F17].

VEGF165b antibody [7F17]

GTX52502
GeneTex
ApplicationsWestern Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman
TargetVEGFA
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    VEGF165b antibody [7F17]
  • Delivery Days Customer
    9
  • Antibody Specificity
    This antibody was selected for its ability to detect human VEGF165b. This antibody showed no cross-reactivity with rhVEGF206.
  • Application Supplier Note
    WB: 1:100 - 1:1000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    Western Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
  • Certification
    Research Use Only
  • Clonality
    Monoclonal
  • Clone ID
    7F17
  • Concentration
    200 ug/ml
  • Conjugate
    Unconjugated
  • Gene ID7422
  • Target name
    VEGFA
  • Target description
    vascular endothelial growth factor A
  • Target synonyms
    MVCD1; vascular endothelial growth factor A; vascular endothelial growth factor A121; vascular endothelial growth factor A165; vascular permeability factor; VEGF; VPF
  • Host
    Mouse
  • Isotype
    IgG1
  • Protein IDP15692
  • Protein Name
    Vascular endothelial growth factor A
  • Scientific Description
    This gene is a member of the PDGF/VEGF growth factor family. It encodes a heparin-binding protein, which exists as a disulfide-linked homodimer. This growth factor induces proliferation and migration of vascular endothelial cells, and is essential for both physiological and pathological angiogenesis. Disruption of this gene in mice resulted in abnormal embryonic blood vessel formation. This gene is upregulated in many known tumors and its expression is correlated with tumor stage and progression. Elevated levels of this protein are found in patients with POEMS syndrome, also known as Crow-Fukase syndrome. Allelic variants of this gene have been associated with microvascular complications of diabetes 1 (MVCD1) and atherosclerosis. Alternatively spliced transcript variants encoding different isoforms have been described. There is also evidence for alternative translation initiation from upstream non-AUG (CUG) codons resulting in additional isoforms. A recent study showed that a C-terminally extended isoform is produced by use of an alternative in-frame translation termination codon via a stop codon readthrough mechanism, and that this isoform is antiangiogenic. Expression of some isoforms derived from the AUG start codon is regulated by a small upstream open reading frame, which is located within an internal ribosome entry site. [provided by RefSeq, Nov 2015]
  • Reactivity
    Human
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203

References

  • Alternative splicing of VEGFA is regulated by RBM10 in endometrial cancer. Dou XQ et al., 2020 Jan, Kaohsiung J Med Sci
    Read more